|
FKBP3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.409360E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.758640E-01 |
| Normal-vs-Stage2 |
9.187600E-01 |
| Normal-vs-Stage3 |
1.319430E-01 |
| Normal-vs-Stage4 |
7.458100E-03 |
| Stage1-vs-Stage2 |
1.675830E-01 |
| Stage1-vs-Stage3 |
6.983600E-01 |
| Stage1-vs-Stage4 |
5.314100E-02 |
| Stage2-vs-Stage3 |
1.396230E-01 |
| Stage2-vs-Stage4 |
1.596280E-02 |
| Stage3-vs-Stage4 |
1.779620E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.208430E-01 |
| Normal-vs-AfricanAmerican |
4.145800E-01 |
| Normal-vs-Asian |
3.153000E-01 |
| Caucasian-vs-AfricanAmerican |
6.753800E-01 |
| Caucasian-vs-Asian |
8.232800E-01 |
| AfricanAmerican-vs-Asian |
8.949200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.653620E-01 |
| Normal-vs-Female |
1.552830E-01 |
| Male-vs-Female |
9.696200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.078020E-01 |
| Normal-vs-Age(41-60Yrs) |
1.215960E-01 |
| Normal-vs-Age(61-80Yrs) |
4.038400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.291800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.063600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.772000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.864000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.251600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.354200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.345400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.132500E-02 |
| Classical-VS-Follicular |
9.752800E-01 |
| Classical-VS-Other |
9.613600E-01 |
| Classical-VS-Normal |
2.302200E-01 |
| Tall-VS-Follicular |
1.138770E-01 |
| Tall-VS-Other |
2.953000E-01 |
| Tall-VS-Normal |
1.784330E-02 |
| Follicular-VS-Other |
9.787400E-01 |
| Follicular-VS-Normal |
3.658800E-01 |
| Other-VS-Normal |
6.538800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.679400E-01 |
| Normal-vs-N1 |
2.536400E-02 |
| N0-vs-N1 |
1.523580E-01 |
|
|
